V ascular smooth muscle cell (VSMC) proliferation, hypertrophy, and migration underlie most hypertrophic vascular diseases, including atherosclerosis, hypertensive wall hypertrophy, and restenosis after vascular injury. 1 Catecholamines stimulate cultured VSMCs to undergo these same processes [2] [3] [4] [5] through stimulation of ␣ 1 -adrenoceptors (␣ 1 -ARs), which are G protein-coupled receptors (GPCRs). Recent studies have shown that catecholamine-induced proliferation is strongly augmented and contributes to hypertrophic growth and restenosis in experimental vascular injury. Thus, treatment of rat aorta in organ culture with norepinephrine (NE) elicited VSMC and adventitial fibroblast proliferation and hypertrophy that were significantly increased after balloon angioplasty. 6 Similarly, chronic local elevation of vascular wall NE in vivo worsened neointimal growth and lumen loss after rat carotid injury. 7 Moreover, chronic local blockade of ␣ 1A -ARs, but not other AR subtypes, reduced neointimal expansion and lumen narrowing in the rat carotid injury model. 7 In agreement, chronic systemic administration of an ␣ 1A -AR antagonist, at levels without effects on arterial pressure or regional resistance, caused dose-dependent inhibition of neointimal growth and lumen loss. 8 These and other studies 9 suggest that catecholamines may contribute to excessive growth of vascular wall cells in vascular diseases and injury after surgical procedures. Thus, catecholamines could be direct risk factors for vascular disease, which highlights the need to define the intracellular pathways mediating their trophic activity.
Reactive oxygen species (ROS) such as superoxide anions (O 2 Ϫ· ) and hydrogen peroxide (H 2 O 2 ) are important second messengers in intracellular signal transduction pathways for several functions, including VSMC growth. 10 In particular, ROS mediate proliferation by several GPCR agonists and growth factors in VSMCs, including angiotensin II, 11 thrombin, 12 platelet-derived growth factor (PDGF), 13 and endothelin-1. 14 The membrane-bound NAD(P)H oxidase is the major source of ROS production in both the intact vessel wall and cultured VSMCs. [15] [16] [17] [18] The enzyme generates O 2 Ϫ· by NAD(P)H-derived one-electron reduction of molecular oxygen, that subsequently may be rapidly dismutated to form H 2 O 2 . 19 This "vascular" oxidase shows similarities with the better characterized "phagocytic" NAD(P)H oxidase. The phagocytic oxidase consists of a membrane-associated flavocytochrome (cytochrome b 558 ) that is composed of two glycoproteins, gp91 phox (Nox 2) and p22 phox , and the cytosolic components, p47 phox , p67 phox , p40 phox , and the G protein Rac1/ 2. 19 Activation of the phagocytic NAD(P)H oxidase requires association of p47 phox and p67 phox , followed by their targeting to the plasma membrane by Rac-GTP. 19 p47
phox plays a key role in assembly and activation of the oxidase, because in its absence, p67
phox fails to assemble with the membrane-bound subunits. 19 In addition, p47 phox regulates electron transfer from flavin adenine dinucleotide (FAD) to the heme center of cytochrome b 558 , leading to O 2 Ϫ· generation. 19 Although the vascular NAD(P)H oxidase is believed to be similar to the phagocytic oxidase, isoforms of all the vascular subunits have not been identified and the mechanism of activation is not completely understood. Several other ROS-generating systems, including the mitochondrial electron transport chain, nitric oxide synthase, xanthine oxidase, and cyclooxygenase have also been implicated in intracellular signaling cascades leading to changes in cell structure, function, and proliferation. 20 However, the NAD(P)H oxidase is a much larger source of induced ROS in the vascular wall than these other enzymes. Besides activation by certain extracellular agonists, mechanical and chemical injury of arteries also strongly increase NAD(P)H oxidase-associated ROS generation, VSMC proliferation, and neointimal formation that are inhibited by treatment with antioxidants. [21] [22] [23] The responsible pathways mediating the proliferative, hypertrophic, and chemotactic actions of catecholamines in VSMCs are not well understood. Norepinephrine-induced proliferation of VSMCs is mediated by extracellular signalregulated kinases (ERK) 1/2. 4,24 These mitogen-activated protein kinases (MAPK) also appear to mediate ␣ 1 -ARstimulated hypertrophy in cultured cardiomyocytes. 25 Although ROS generation is involved in ERK1/2-dependent hypertrophy of cultured cardiomyocytes by ␣ 1 -AR stimulation, 26 only one report suggests ROS may be involved in adrenergic proliferation of cultured VSMCs. 27 Furthermore, no studies have examined this question in the intact vessel wall. Therefore, the purpose of the present study was to determine if ROS mediate ␣ 1 -AR-induced VSMC growth in vitro and in the vascular wall ex vivo, and whether the NAD(P)H oxidase is the source of catecholamine-stimulated ROS generation.
Materials and Methods
Balloon injury of the rat thoracic aorta was performed according to standard methods. 6 Four days after injury, the aorta was placed into organ culture as described previously, 3, 4, 6, 28 with circumferential wall tension set to 0.45 g per mm vessel length to favor the quiescent VSMC phenotype. 3 For cell culture, VSMCs were enzymatically dispersed from rat thoracic aortae and used at passages 3 to 4, as described previously, 3 and from p47
phoxϪ/Ϫ and wild-type mice, used between passages 6 to 9. Cells were carried 2 days beyond confluence and growth-arrested for 2 days in serum-free defined medium. Aortae and cultured cells were pretreated with drugs for 1 hour before addition of vehicle or NE. Medium was changed and drugs re-added at 24 hours. After 48 hours in culture, vessel length was measured and intima-media was separated from adventitia as described previously for measurement of DNA and protein content. 3, 4, 28 Protein synthesis was measured during the last 24-hour interval using [ 35 S]methionine incorporation. 4 The oxidative fluorescent probe dihydroethidium (DHE) and confocal microscopy were used to detect in situ levels of ROS in aorta sections. 29 Images were acquired by an observer blinded to the treatment groups. The aconitase assay was used to measure ROS generation in cultured cells. 30 p47 phox mRNA expression was measured by reverse transcription-PCR (RT-PCR). 31 Data are expressed as meanϮSEM. Statistical analysis was performed using Student's t test, with significance defined as PϽ0.05.
An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results

Norepinephrine-Induced Growth of Injured Aorta Media Is Inhibited by Antioxidants
To test the hypothesis that catecholamines' mitogenic actions are mediated through generation of ROS, we first investigated the effects of antioxidants on NE-induced growth in aortae that had been balloon-injured 4 days earlier in vivo and then placed into organ culture. Consistent with our previous study, 6 NE (1 mol/L, 48 hours) increased protein synthesis (171Ϯ14% of vehicle) and DNA content (135Ϯ7%) ( Figure  1 ). Norepinephrine-induced growth was abolished by the antioxidants Tiron and NAC, as well as with DPI, an inhibitor of NAD(P)H oxidase and other flavin-containing enzymes. NAC alone had no effect. DPI alone lowered baseline protein synthesis, an effect that has been noted elsewhere. 32 Protein synthesis was not measured in the Tiron alone group.
Norepinephrine Augments ROS Production in Aorta Media
We next used in situ dihydroethidium (DHE) confocal microscopy to determine if NE augments ROS generation ( Figure 2 ). Norepinephrine enhanced DHE intensity in injured media by 167Ϯ13% of vehicle (average response of Figures 2E and 2F, nϭ14) . The increase was abolished by NAC and DPI and dose-dependently inhibited by Tiron. Tiron and NAC alone inhibited baseline activity ( Figure 2E ), possibly reflecting an effect of injury itself. The increase in DHE intensity induced by NE was not blocked by inhibition of the MAPK (ERK1/2) kinase, MEK1/2, with PD-98059 or UO-126, or by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG-1478 ( Figure 2F ). These results suggest that the ROS-dependent signaling step in the adrenergic trophic pathway is upstream of the EGFR-ERK1/2 pathway. PD-98059 and AG-1478 had small inhibitory effects alone, suggesting that injury itself may increase ROS and activate the EGFR-ERK pathway.
To confirm that DHE fluorescence reflects ROS levels, sections from aortae previously treated for 48 hours with NE were preincubated for 5 minutes with high levels of DPI (50 mol/L) or Tiron (20 mmol/L) before incubation with DHE. Both agents strongly reduced the NE signal by 84Ϯ3% (nϭ8) and 60Ϯ9% (nϭ5), respectively.
Norepinephrine Induces ROS-Dependent Proliferation in Adventitia
Like medial VSMCs, stimulation of ␣ 1 -ARs on adventitial fibroblasts (AFBs) causes their proliferation and adventitial thickening, which are strongly increased after injury in both organ culture 6 and in vivo. 7 In the present study, results for adventitia were similar to media for all groups in Figure 1 . Norepinephrine tended to increase protein synthesis and DNA content by 140Ϯ18% and 118Ϯ10% of vehicle (PϽ0.11 and PϽ0.14, nϭ5 per group, respectively), and NAC prevented these increases (84Ϯ15% and 99Ϯ7%, respectively, nϭ6 per group). Tiron and DPI also inhibited adventitial growth by NE, and all three inhibitors had no significant effect alone. Norepinephrine caused an increase in DHE fluorescence over vehicle [7Ϯ1 (nϭ10) versus 12Ϯ2 (nϭ14), fluorescence units, Pϭ0.02; Figure 2 ], and changes similar to those obtained for media were also obtained for adventitia for the other treatment groups shown in Figure 2 .
Norepinephrine Effects in Uninjured Aorta
Because the uninjured artery is less sensitive than the injured artery to the trophic effect of NE, 6, 7 we performed a more limited study of uninjured aorta and only examined media. Norepinephrine (1 mol/L, 48 hours) caused a small nonsignificant increase in protein synthesis (112Ϯ11% of vehicle, nϭ6). Tiron (5 mmol/L) inhibited this response (78Ϯ4%, PϽ0.05, nϭ6) and had an inhibitory effect alone (59Ϯ5%, PϽ0.001, nϭ6) as reported in cell culture. 33 Changes in DNA content mimicked these results. Norepinephrine increased DHE fluorescence (71Ϯ4) above vehicle (34Ϯ4, PϽ0.001, nϭ6), and this was partially inhibited by Tiron (51Ϯ4, PϽ0.01, nϭ6) but unaffected by AG-1478 (1 mol/L) (62Ϯ7, nϭ6). Tiron and AG-1478 had no effects alone.
Phenylephrine Increases Intracellular ROS Production in Cultured VSMCs
To confirm the DHE results, intracellular levels of ROS were determined by their ability to inhibit aconitase activity in vitro. 30 Stimulation of cultured VSMCs with the selective ␣ 1 -AR agonist phenylephrine (PE) induced a time-dependent decline in aconitase activity, with a maximum response at 10 minutes (Ϫ45.3Ϯ8.5%) that remained reduced at 60 minutes ( Figure 3A) . The 10-fold higher concentration of PE than NE used herein reflects PE's known 10-fold lower potency for activation of ␣ 1 -ARs. Maximal trophic concentrations of NE (1 mol/L) and thrombin (1 U/mL), measured after 20 minutes exposure, were equi-effective: aconitase activity was decreased Ϫ37.2Ϯ5.5% by NE (nϭ4) and Ϫ34.2Ϯ7.6% by thrombin (nϭ4). Thrombin served as a positive control for generation of ROS in VSMCs. 12 Inhibition of aconitase activity by PE (at 10 minutes) was concentration-dependent, with potent inactivation at 10 mol/L PE (Ϫ61.8Ϯ3.9%) ( Figure 3B ). Reduction in aconitase activity was inhibited by Tiron and the SOD mimetic MnTBAP ( Figure 3C ). Tiron and MnTBAP had no effect alone, although there was a trend for MnTBAP to increase baseline activity (ie, to lower basal ROS), as reported by others. 34 
Phenylephrine-Induced Growth of VSMCs Is Inhibited by Catalase
To determine the relative roles of O 2 Ϫ· and H 2 O 2 in catecholamine-induced VSMC growth, PEG-SOD and PEG-catalase were examined. The increase in DNA and protein content induced by PE was little affected by PEG-SOD, but abolished by PEG-catalase (Figure 4 ).
Prazosin Blocks Phenylephrine-Induced ROS Production and Growth of VSMCs
To confirm our previous studies showing that catecholamine trophic effects are ␣ 1 -AR dependent [3] [4] [5] [6] [7] [8] and to determine if their ROS dependence, shown herein, is also ␣ 1 -AR dependent, the ␣ 1 -AR antagonist prazosin was examined. Prazosin inhibited both ROS production (aconitase inhibition; Figure  5A ) and VSMC growth ( Figure 5B ). 
Phenylephrine-Stimulated ROS Generation and Proliferation Are Abolished in p47
phox؊/؊ VSMCs
To examine if catecholamine-stimulated ROS production and VSMC growth are mediated by the NAD(P)H oxidase, aortic VSMCs from p47 phox -null mice were studied. As in rat aortic VSMCs, PE caused a reduction in aconitase activity in wild-type cells that was abolished in p47
phoxϪ/Ϫ cells ( Figure  6A ). Thrombin served as a positive control for p47 phoxdependent reduction in aconitase activity. 31 Baseline levels of ROS were not lower in p47
phoxϪ/Ϫ cells (ie, basal aconitase activity was not greater) than in wild-type cells (0.31Ϯ0.01 versus 0.34Ϯ0.02 mol/L NADPH/min per g protein, respectively), in agreement with one 35 but not another report. 31 Elimination of PE-induced reduction in aconitase activity in p47 phoxϪ/Ϫ cells was associated with inhibition of PE-mediated growth ( Figure 6B ). Furthermore, stimulation of wild-type VSMCs by PE for 1 hour promoted enhanced transcript levels of p47 phox . The expected absence of expression in p47
phoxϪ/Ϫ cells served as a negative control ( Figure 6C ).
Inhibitors of NAD(P)H Oxidase but not of Other Cellular ROS Sources Inhibit PE-Induced Proliferation
Because additional enzymes besides NAD(P)H oxidase are known to generate low levels of ROS, 20 we tested inhibitors of them on PE-induced proliferation. In contrast to DPI and the more specific NAD(P)H-oxidase inhibitor, apocynin, that abolished PE-stimulated proliferation ( Figure 7A ), inhibitors of nitric oxide synthase (L-NAME), cyclooxygenase (indomethacin), xanthine oxidase (allopurinol), and cytochrome P450 oxidases (17-octadecynoic acid) had no effect on the PE-mediated increase in DNA content ( Figure 7B ). These inhibitors had no effect alone. At a concentration that reduces oxidative phosphorylation (30 mol/L), 36 the NADH dehydrogenase inhibitor rotenone also had no effect. However, a higher concentration (100 mol/L) did reduce the DNA increase by PE ( Figure 7C ). Data for protein content (not shown) mimicked these DNA results.
Discussion
This is the first study to demonstrate that ␣ 1 -AR-induced VSMC growth in both cell culture and, importantly, the intact vascular wall is mediated by generation of ROS derived from the vascular NAD(P)H oxidase. The ROS-sensitive step in this pathway is upstream of activation of the EGFR and ERK1/2, and appears to be mediated primarily by H 2 O 2 . A previous report in cultured VSMCs suggested catecholamines might increase ROS. 27 In that study, PE increased 2Ј-7Ј-dichlorofluorocein diacetate fluorescence and DNA synthesis, and catalase and NAC reduced DNA synthesis by Ϸ40%. These results are consistent with a similar requirement for ROS generation in ␣ 1 -AR-induced ERK1/2-dependent hypertrophy of cultured cardiomyocytes. 26 We previously found that NE induces growth of medial VSMCs in rat aorta maintained in organ culture, and that this is strongly augmented by balloon injury 4 or 12 days earlier in vivo. 6 This mitogenic effect is mediated by the ␣ 1A -AR subtype, but not by the ␣ 1D -, ␣ 2D -, or ␤-ARs that instead are vasoactive in this vessel. Furthermore, ␣ 1 -AR-induced growth contributes significantly to restenosis after rat carotid 
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balloon injury 7, 8 and injury-induced hypertrophic outward remodeling in mice. 37 Results consistent with these observations were obtained in the present study, where NE caused significant proliferation of VSMCs in rat aorta studied in organ culture after receiving balloon injury 4 days earlier in vivo. This was associated with increased ROS generation (detected by DHE fluorescence). Both proliferation and ROS generation were abolished by Tiron, NAC, and DPI ( Figures  1 and 2) , suggesting that the adrenergic trophic pathway includes a ROS-sensitive step(s). Tiron, NAC, and DPI alone had minimal-to-no inhibitory effects. This likely reflects the effect of injury itself to increase cytokines and growth factors, some of which may activate ROS, together with reduction in the extracellular concentration of these mediators by diffusion into the large (200 mL) tissue culture bath. Although no in vitro system can fully preserve in vivo conditions, the preloaded organ culture model permits VSMCs to be studied in the intact vascular wall. 6 The source of catecholamine-induced ROS generation was not macrophages or neutrophils that are recruited to the vascular wall after injury. Rather, NE induced a mostly uniform increase in intracellular DHE fluorescence across the media ( Figure 2C ). We and others have shown that the media is composed almost entirely of cells expressing ␣-smooth 
VSMCs. p47
phoxϪ/Ϫ (p47 Ϫ/Ϫ ) or wild-type (wt) VSMCs were stimulated with PE or thrombin (Thr) for 10 minutes and aconitase activity was measured (A). p47 phoxϪ/Ϫ or wild-type VSMCs were treated with PE for 48 hours, and DNA and protein content were determined from cell extracts (B). Data are percent of control or vehicle-treated cells and are meanϮSEM (nϭ3 to 9). C, RT-PCR of p47 phox and GAPDH in p47 phoxϪ/Ϫ and wild-type VSMCs after phenylephrine stimulation for 60 minutes. Effect of inhibitors of ROS-generating enzymes on phenylephrine-stimulated proliferation. A, DPI and apocynin (Apo) blocked PE-stimulated proliferation. B and C, Inhibition of nitric oxide synthase (L-NAME), cyclooxygenase (indomethacin; Indo), xanthine oxidase (allopurinol; Allo), cytochrome P450 (17-octadecynoic acid; ODYA), and NADH dehydrogenase (rotenone; Rot) had no effect on PE-induced increase in DNA content. VSMCs were pretreated with the above inhibitors for 1 hour and stimulated with PE for 48 hours. DNA and protein content were determined from cell lysates. Data are percent of vehicle-treated cells and are meanϮSEM (nϭ4). muscle actin, when examined 4 days after balloon injury. 6 In addition, PE also caused cultured VSMCs to generate ROS, and with an efficacy comparable to thrombin (Figures 3 and 6A) .
To examine the source of ROS, we tested DPI and a more specific inhibitor of NAD(P)H oxidase, apocynin, on catecholamine-stimulated proliferation of cultured VSMCs. Both abolished PE-induced increases in DNA and protein content ( Figure 7A ).
Because DPI inhibits several flavin-containing enzymes that generate ROS, besides NAD(P)H oxidase, because apocynin may also have other actions, and because few specific inhibitors of the oxidase are available (p22 phox -antisense, gp91ds-tat and dominant-negative p67 phox ), we examined primary cultures of aortic VSMCs obtained from mice genetically deficient in p47 phox , a key regulatory subunit of NAD(P)H oxidase. ROS generation and proliferation induced by PE in wild-type cells were both abolished in p47 phoxϪ/Ϫ cells ( Figure 6 ). Consistent with increase in ROS production, PE caused increased p47
phox transcription levels at 1 hour ( Figure 6C ).
Although these findings suggest that the NAD(P)H oxidase mediates the trophic action of catecholamines on VSMCs, we examined whether induction of other DPI-sensitive ROSgenerating enzymes might participate. Phenylephrine-induced proliferation was unaffected by inhibition of nitric oxide synthase (NOS), cyclooxygenase, xanthine oxidase, or cytochrome P450 oxidases ( Figure 7B ). Although inhibition of NOS with L-NAME can inhibit VSMC proliferation by PDGF, 38 our studies suggest that the pathway mediating ␣ 1 -AR induced proliferation does not involve nitric oxide or the above oxidases. Interestingly, L-NAME also had no effect on ␣ 1 -AR-mediated hypertrophy of cardiomyocytes. 26 The NADH dehydrogenase inhibitor, rotenone (30 mol/L), also did not inhibit PE-induced proliferation. However, a higher concentration of rotenone (100 mol/L) caused a decrease in PE proliferation. This may reflect a reduction in mitochondrial oxidative phosphorylation 36 and stimulation of apoptosis, 39 an effect that is suggested by the decrease in baseline DNA content caused by this concentration ( Figure 7C ).
Generation of ROS by PE was rapid, persisted for at least 60 minutes, was dose-dependent, and extended over the same dose range observed for NE-evoked contraction (Figure 3) . We have shown in organ culture that ␣ 1 -AR-mediated proliferation also extends over this same range. 6 Importantly, ␣ 1 -adrenergic constriction is not associated with altered ROS activity and is not affected by inhibition of the NAD(P)H oxidase or ROS. 40 These correlations strengthen the concept that the signaling pathway used by catecholamines to stimulate VSMCs growth in vivo involves the ROS-sensitive pathway identified in the present study. In addition, the maximum inactivation of aconitase after 10 minutes exposure to PE (40% to 60%), which we used to measure ROS production, is similar to that reported for thrombin 31 and other studies using this assay. 41 To validate this assay, we demonstrated that PE inhibition of aconitase activity was abolished by concomitant treatment with Tiron or MnTBAP ( Figure  3C ). We also found that NE showed the same maximal efficacy as the ␣ 1 -AR agonist PE, indicating that simultaneous stimulation of ␣ 2D -and ␤-ARs that are also present does not influence ROS generation. This is in agreement with the effect of prazosin to inhibit ROS production and VSMC growth ( Figure 5 ) and our previous results showing no involvement of ␣ 2D -and ␤-ARs in catecholamine-induced growth of the intact aorta and carotid artery studied in organ culture 6 and in vivo. 7 The maintained ROS generation by PE ( Figure 3A) is similar to the action of certain other ROSgenerating mitogenic factors. For example, angiotensin II induces biphasic production of ROS in VSMCs, involving a rapid early peak at 30 seconds, followed by sustained gener- 
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ation for at least 6 hours. 11, 42 Likewise, induction of ROS by thrombin was evident at 15 minutes, elevated further at 1 hour, and remained above baseline for at least 6 hours. 12 In most cell types, O 2 Ϫ· generated by NAD(P)H oxidase is rapidly converted by SOD to H 2 O 2 . In cultured VSMCs, H 2 O 2 mediates the mitogenic effects of angiotensin II, 43 thrombin, 12 and PDGF, 13 and is itself mitogenic. 44 In agreement with these studies, we found that proliferation of VSMCs by PE was abolished by membrane permeant PEG-catalase ( Figure  4) . In contrast, PEG-SOD had minimal if any effect. This suggests that SOD is not limiting in the presence of PE stimulation, and also that O 2 Ϫ· itself or other ROS arising upstream of SOD (eg, peroxynitrite) have little or no direct role in mediating adrenergic proliferation. Similar results were reported for thrombin. 12 We have evidence that activation of the intrinsic tyrosine kinase activity of EGFR and its known downstream activation of the raf1-MEK1/2-ERK1/2 pathway are required for ␣ 1 -AR-induced growth of VSMCs in rat aorta studied in organ culture (unpublished data, H. Zhang, J.E. Faber, 2003) . The EGFR tyrosine kinase inhibitor, AG-1478, and the MEK1/2 inhibitors, PD-98059 and UO-126, each abolished catecholamine-induced protein synthesis and DNA accumulation (while having no effects alone). This was associated with augmented phosphorylation of EGFR and ERK1/2 as assessed by immunoblot that was sustained for the duration of PE exposure. To begin to examine whether the ROS-sensitive step in the adrenergic trophic pathway is upstream or downstream of EGFR activation, in the present study, we determined the effect of these above-mentioned agents on ROS generation by DHE fluorescence ( Figure 2F ). In contrast to their inhibitory effects on adrenergic growth, none had a significant effect on NE-induced ROS activity. This suggests that the ROS-sensitive step resides upstream of EGFR and ERK activation. Norepinephrine-induced ERK activation in cardiomyocytes has also been shown to be dependent on a ROS-sensitive step. In contrast, endothelin-1 14 and angiotensin II 45 activation of ERK in VSMCs is not ROS-dependent; although there is controversy on this point for angiotensin II. 46 Figure 8 is a proposed signaling pathway for catecholamine-mediated VSMC growth, based on our present results. Stimulation of ␣ 1 -ARs by blood-borne NE or by increased release of NE from vascular nerves induced by injury 47 is proposed to activate NAD(P)H oxidase-dependent generation of O 2 Ϫ· and in turn H 2 O 2 . Hydrogen peroxide causes activation of the EGFR-ERK1/2 pathway and subsequent induction of protein synthesis and proliferation. Although identification of the steps that are proximal and distal to the indicated mediators in this pathway await investigation, the pathway suggests a direct link or risk factor status may exist between catecholamines, injury, and the progression of vascular disease. It is well known that O 2 Ϫ· inactivates nitric oxide that serves as a tonically active, antiproliferative signal. It is also well known that promoters of vascular injury and disease augment ROS activity. This effect was recently underscored by the identification of an apparently crucial role for NAD(P)H oxidase in neointimal response to rat carotid balloon injury. 48 The evidence we present herein for dependence of adrenergic growth on a ROS second messenger, together with the effects of injury on ROS and ROS on nitric oxide availability, may explain why injury so strongly amplifies the mitogenic action of catecholamines: an effect that our recent in vivo evidence suggests contributes to neointimal growth and hypertrophic remodeling in animal models of vascular disease. 7, 8 As such, therapeutic agents that reduce oxidative stress or interfere with generation of intracellular ROS may derive their salutary effect, in part, by amelioration of the hypertrophic effects of catecholamines induced by vascular injury and disease. was given for analgesia. All procedures were conducted per NIH guidelines.
On-line Data
Aorta Organ Culture. Four days after balloon injury, anesthetized rats were perfused transcardially with sterile 4°C phosphate-buffered saline (PBS) at 100 mmHg. The descending thoracic aorta was viewed (100x) under a pool of 4°C PBS, and the periadventitial connective tissue and intercostal arteries were removed aseptically. An organ culture system described in detail elsewhere [1] [2] [3] [4] was used to maintain the aorta under circumferential wall tension (0.45 g per mm vessel length) in serum-free media consisting of 50% Dulbecco's modified Eagle's medium (DMEM), 50% F-12 media, supplemented with 5 mg/L transferrin, 100 µmol/L ascorbic acid, 6 ng/ml selenium, 100 U/ml penicillin and 100 µg/ml streptomycin, in a 37°C, 5% CO 2 incubator. Maintenance of circumferential wall tension favors the quiescent VSMC phenotype 2, 5, 6 , whereas a neointima forms spontaneously and VSMC marker proteins that characterize the contractile phenotype decline when vessels are placed into organ culture in the absence of load. 5 Tiron or DPI, in addition to DHE, was directly added to a given vessel section.
After incubation, sections were maintained humidified and light protected at 4°C
and immediately imaged in random sequence on a Leica confocal microscope (488 nm argon laser; 590 nm long pass filter). Confocal and laser settings were maintained identical in each experiment and images were acquired by an observer blinded to the treatment groups. Results were pixilated and quantified using Scion Image ® .
Cell Culture. VSMCs were isolated from male Sprague-Dawley rat thoracic aortae by enzymatic digestion as described previously. 2 Cells were grown in M199 supplemented with 10% fetal bovine serum (FBS), 200 mg/L Lglutamine, 100 U/ml penicillin and 100 µg/ml streptomycin and passaged at ~95% confluence with 0.1% trypsin/ EDTA twice a week. For experiments, cells were used at passages 3 to 4, carried 2 days beyond confluence, and growtharrested for 2 days in serum-free defined medium, consisting of 50% DMEM, 50% F-12 media, 5 mg/ml transferrin, 100 µ/mol/L ascorbic acid, 100 U/ml penicillin and 100 µg/ml streptomycin. 
